Liuxiang Chu

769 total citations
18 papers, 622 citations indexed

About

Liuxiang Chu is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Liuxiang Chu has authored 18 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 8 papers in Molecular Biology and 7 papers in Biomaterials. Recurrent topics in Liuxiang Chu's work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and RNA Interference and Gene Delivery (6 papers). Liuxiang Chu is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and RNA Interference and Gene Delivery (6 papers). Liuxiang Chu collaborates with scholars based in China, South Korea and United States. Liuxiang Chu's co-authors include Kaoxiang Sun, Aiping Wang, Xiuju Yan, Zimei Wu, Hongjie Mu, Xin Yu, Mingyu Zhao, Lixiao Xu, Fenghua Fu and Peng Xue and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Liuxiang Chu

18 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liuxiang Chu China	10	259	229	205	161	59	18	622
Sascha Wien Germany	9	165 0.6×	156 0.7×	85 0.4×	75 0.5×	42 0.7×	13	445
Sibel Bozdağ Pehlivan Türkiye	13	173 0.7×	196 0.9×	252 1.2×	139 0.9×	19 0.3×	25	652
Janet L. Manias Canada	13	499 1.9×	223 1.0×	95 0.5×	121 0.8×	26 0.4×	15	941
Ilaria Ottonelli Italy	14	170 0.7×	196 0.9×	80 0.4×	133 0.8×	32 0.5×	23	418
Anjali Hirani United States	11	126 0.5×	240 1.0×	106 0.5×	76 0.5×	9 0.2×	20	514
Edmund Carvalho India	10	263 1.0×	83 0.4×	79 0.4×	71 0.4×	15 0.3×	13	614
Olga Maksimenko Russia	11	292 1.1×	572 2.5×	268 1.3×	298 1.9×	81 1.4×	16	874
Daniela Triolo Italy	15	194 0.7×	105 0.5×	42 0.2×	62 0.4×	30 0.5×	21	713
Roberta Dal Magro Italy	13	370 1.4×	354 1.5×	154 0.8×	206 1.3×	38 0.6×	23	792
Bruna dos Santos Rodrigues United States	13	471 1.8×	302 1.3×	78 0.4×	154 1.0×	35 0.6×	29	798

Countries citing papers authored by Liuxiang Chu

Since Specialization

Citations

This map shows the geographic impact of Liuxiang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liuxiang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liuxiang Chu more than expected).

Fields of papers citing papers by Liuxiang Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liuxiang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liuxiang Chu. The network helps show where Liuxiang Chu may publish in the future.

Co-authorship network of co-authors of Liuxiang Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Liuxiang Chu. A scholar is included among the top collaborators of Liuxiang Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liuxiang Chu. Liuxiang Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Chu, Liuxiang, Yanyan Zhao, Lixiao Xu, et al.. (2024). The Tumor-Derived Exosomes Enhanced Bevacizumab across the Blood–Brain Barrier for Antiangiogenesis Therapy against Glioblastoma. Molecular Pharmaceutics. 22(2). 972–983. 9 indexed citations

Chu, Liuxiang, Yanyan Zhao, Aiping Wang, et al.. (2024). Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy. International Journal of Pharmaceutics. 660. 124262–124262. 10 indexed citations

Wang, Aiping, Li Jiang, Xuan Zhou, et al.. (2024). Targeted thermosensitive liposomes loaded with gold nanoparticles and temozolomide hexadecanoate for the synergistic photothermal-chemotherapy treatment of glioblastoma. Journal of Pharmaceutical Sciences. 114(2). 1196–1204. 3 indexed citations

Zhang, Chunyan, Liuxiang Chu, Keke Li, & Maocai Yan. (2024). Release mechanism and pharmacodynamics of entecavir micro spheres.. PubMed. 37(1). 107–113. 1 indexed citations

Wang, Ru, et al.. (2023). Homotypic targeted nanoplatform enable efficient chemoimmunotherapy and reduced DOX cardiotoxicity in chemoresistant cancer via TGF-β1 blockade. Journal of Controlled Release. 361. 147–160. 8 indexed citations

Wang, Ru, Yiying Sun, Xiaoyan He, et al.. (2023). Tumor microenvironment-responsive micelles assembled from a prodrug of mitoxantrone and 1-methyl tryptophan for enhanced chemo-immunotherapy. Drug Delivery. 30(1). 2182254–2182254. 8 indexed citations

Zhang, Tianyu, Ru Wang, Yiying Sun, et al.. (2023). Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity. Drug Delivery. 30(1). 2189118–2189118. 12 indexed citations

Wang, Siqi, Aiping Wang, Liuxiang Chu, et al.. (2022). Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration. Frontiers in Pharmacology. 13. 965789–965789. 15 indexed citations

Wang, Aiping, Siqi Wang, Liuxiang Chu, et al.. (2022). Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study. Molecular Pharmaceutics. 19(4). 1219–1229. 52 indexed citations

10.

Han, Junping, et al.. (2021). Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study. Journal of Pharmaceutical Sciences. 110(10). 3431–3438. 8 indexed citations

11.

He, Xiuting, Zhongcheng Cao, Liuxiang Chu, et al.. (2021). Preparation and evaluation of SN-38-loaded MMP-2-responsive polymer micelles. Journal of Drug Delivery Science and Technology. 66. 102596–102596. 3 indexed citations

12.

Wang, Aiping, Xiuju Yan, Rongcai Liang, et al.. (2019). Preparation and evaluation of lactic acid acylated exenatide and its long-acting preparation. Pharmaceutical Development and Technology. 24(10). 1229–1235. 5 indexed citations

13.

Shi, Yanan, Haiyan Hu, Liuxiang Chu, et al.. (2019). Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption. Molecular Pharmaceutics. 16(2). 518–532. 64 indexed citations

14.

Tang, Shengnan, Aiping Wang, Xiuju Yan, et al.. (2019). Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease. Drug Delivery. 26(1). 700–707. 130 indexed citations

15.

Chu, Liuxiang, Aiping Wang, Ling Ni, et al.. (2018). Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting. Drug Delivery. 25(1). 1634–1641. 105 indexed citations

16.

Yan, Xiuju, Lixiao Xu, Chenchen Bi, et al.. (2018). Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects. International Journal of Nanomedicine. Volume 13. 273–281. 63 indexed citations

17.

Mu, Hongjie, Yiyun Wang, Yongchao Chu, et al.. (2018). Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization. Drug Delivery. 25(1). 1372–1383. 92 indexed citations

18.

Wang, Tian, Shanshan Zhao, Yujiao Yang, et al.. (2014). Protective effects of escin against indomethacin-induced gastric ulcer in mice. Toxicology Mechanisms and Methods. 24(8). 560–566. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact